Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-20-031567)

Filing Details

Accession Number:: 0001104659-20-031567
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-03-10 21:25:46
Reporting Period:: 2020-03-06

Accepted Time:: 2020-03-10 21:25:46
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
3116	Akorn Inc	AKRX	Pharmaceutical Preparations (2834)	720717400

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1674254	Jonathan Kafer	C/O Akorn, Inc. 1925 W. Field Court, Suite 300 Lake Forest IL 60045	Evp & Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2020-03-06	11,088	$1.02	193,257	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The amount of shares beneficially owned includes 188,846 unvested Restricted Stock Units (RSUs) and 4,411 shares owned outright.